Illuminating the microbiome's functional "dark matter."💡A huge gap in #systemsbiology is that most microbial proteins are uncharacterized. This new paper from @hutlab, introduce FUGAsseM, a multiomics method to predict protein function.
Check it out!
https://t.co/inVyV2J5Xp
We are running a massive online open course on AMR databases starting end of the month. Its completely free, study at your own pace and its ~15 hours overall over the 3 weeks (although you can finish any time in a year). Please spread in your networks! https://t.co/n6LU8VDeTw
My favourite discovery ever has just come online. Can I please tell you about some seriously wacky molecular biology? The story starts with a reverse transcriptase that SOMEHOW defends bacteria from viruses.
(👇 I recommend sound ON for the video 🎹)
1/
Excited to share our latest pre-print!
We investigated the dosing and delivery requirements for phage therapy in a mouse wound infection model and developed a sustained phage release hydrogel dressing, with our amazing collaborators in @chaudhurilab
https://t.co/rZyPeDz8jR
ChatGPT can now create Flowcharts and Diagrams.
No more wasting hundreds of hours creating visuals for presentations or research papers.
Here’s how to do it for free in a few minutes:
Inspiring essay by Roberto Kolter. This should be taught before university: knowing how to ask the right questions, the ones we're interested in, not just those for a 'good' paper. This makes a good researcher, IMO. https://t.co/ccUg68VAK3
🔊Check out our work in @ScienceMagazine. We identify a new weak point (TCG codon) in the codon table of mammalian cells and recode it into non-canonical amino acids (ncAAs) with impressive efficiency and selectivity. This strategy, rare codon recoding (RCR), is very different!
See the latest paper on our Bacteriophage Adherence to Mucus (BAM) work by collaborator Fang Tang
https://t.co/yXBZMWEjKV
Here we test BAM in vivo and show that mucus-adherent phage protects mice from intestinal infection, and leads to increased expression of mucus genes
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
https://t.co/0nN5Pur82F
Miller & Arias explore recent advances in understanding ESKAPE pathogens, including epidemiology, clinical impact, resistance mechanisms and novel therapeutics.
The story of our successful phage therapy treatment of Squeaks the cat (https://t.co/eHhFXXGywk…) was published by both Forbes (https://t.co/sHOyDKhuIk…) and Newsweek (https://t.co/0o65Nq0EvC) 😊